Literature DB >> 17515123

[Alveolar rhabdomyosarcoma of unknown origin mimicking acute leukemia at the initial presentation].

Kan Yamaguchi1, Yuhki Koga, Aiko Suminoe, Yusuke Saito, Akinobu Matsuzaki, Shunsuke Kanno, Tomohito Takimoto, Masahiro Suda, Yoshinao Oda, Toshitaka Muto, Hiroshi Takatsuki, Toshiro Hara.   

Abstract

A 14-year-old boy presented with a short history of general fatigue. Laboratory examination of the peripheral blood revealed white blood cells 11,300/microl, hemoglobin 10.4 g/dl, platelets 45,000/microl, fibrinogen < 50 mg/dl, fibrin/fibrinogen degradation products 536 microg/ml and lactate dehydrogenase 1,684 U/l. A bone marrow aspirate contained 89.6% of undifferentiated tumor cells. A hematological malignancy was suspected and the patient was treated with idarubicin and cytarabine. However, further examination revealed that tumor cells were positive for CD56 and lacked lineage markers of lymphoid or myeloid cells. They were positive for PAS, HHF35 and desmin, and negative for MPO. Reverse transcriptase polymerase chain reaction demonstrated PAX3/FKHR fusion transcripts, confirming the diagnosis of alveolar rhabdomyosarcoma. Radiological examination revealed only one enlarged lymph node being 1.5 cm in diameter at the paraaortic region in the abdomen, and failed to find a primary tumor. After three courses of chemotherapy containing etoposide, cyclophosphamide, pirarubicin, cisplatin and vincristine, tumor cells were eradicated from the bone marrow. The patient received an allogeneic bone marrow transplantation eight months after diagnosis, although he died of hepatic veno-occlusive disease on day 21. Alveolar rhabdomyosarcoma often develops in older children and younger adults, and its bone marrow infiltration may mimic acute leukemia.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17515123

Source DB:  PubMed          Journal:  Rinsho Ketsueki        ISSN: 0485-1439


  7 in total

Review 1.  Childhood rhabdomyosarcoma metastatic to bone marrow presenting with disseminated intravascular coagulation and acute tumour lysis syndrome: review of the literature apropos of two cases.

Authors:  Ewa Bien; Lucyna Maciejka-Kapuscinska; Maciej Niedzwiecki; Joanna Stefanowicz; Anna Szolkiewicz; Malgorzata Krawczyk; Jadwiga Maldyk; Ewa Izycka-Swieszewska; Beata Tokarska; Anna Balcerska
Journal:  Clin Exp Metastasis       Date:  2010-06-02       Impact factor: 5.150

2.  Nasopharyngeal alveolar rhabdomyosarcoma expressing CD56: a mimicker of extranodal natural killer/T-cell lymphoma.

Authors:  Khin Than Win; Ming-Yuan Lee; Tran-Der Tan; Mung-pei Tsai; Armita Bahrami; Susana C Raimondi; Shih-Sung Chuang
Journal:  Int J Clin Exp Pathol       Date:  2013-12-15

3.  Alveolar rhabdomyosarcoma of the head and neck region in older adults: genetic characterization and a review of the literature.

Authors:  Taketoshi Yasuda; Kyle D Perry; Marilu Nelson; Marilyn M Bui; Aejaz Nasir; Robert Goldschmidt; Douglas R Gnepp; Julia A Bridge
Journal:  Hum Pathol       Date:  2008-10-29       Impact factor: 3.466

4.  Complete mimicry: a case of alveolar rhabdomyosarcoma masquerading as acute leukemia.

Authors:  Osamu Imataki; Makiko Uemura; Shumpei Uchida; Shigeyuki Yokokura; Akihiro Takeuchi; Ryo Ishikawa; Akihiro Kondo; Kayoko Seo; Norimitsu Kadowaki
Journal:  Diagn Pathol       Date:  2017-11-02       Impact factor: 2.644

5.  Rhabdomyosarcoma debut masquerading as acute lymphoblastic leukemia: A case report and review of the literature.

Authors:  Bernardo López-Andrade; Maria Antonia Duran; Lourdes Torres; Marta García-Recio; Laura Lo Riso; Alejandro Formica; Rafael F Ramos; Niurka Cerda; Antonia Sampol
Journal:  Clin Case Rep       Date:  2019-07-02

6.  Rhabdomyosarcoma With Diffuse Bone Marrow Metastases.

Authors:  Daniel Huang; Pankaj Watal; Dennis Drehner; Deeksha Dhar; Tushar Chandra
Journal:  Cureus       Date:  2022-02-03

7.  Primary alveolar rhabdomyosarcoma of the bone: two cases and review of the literature.

Authors:  Petra Balogh; Rita Bánusz; Monika Csóka; Zsófia Váradi; Edit Varga; Zoltán Sápi
Journal:  Diagn Pathol       Date:  2016-10-18       Impact factor: 2.644

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.